Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.04 AUD -2.44%
Market Cap: 87.6m AUD

Net Margin
Bioxyne Ltd

17.2%
Current
-71%
Average
3.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.2%
=
Net Income
4.9m
/
Revenue
28.4m

Net Margin Across Competitors

No Stocks Found

Bioxyne Ltd
Glance View

Market Cap
86.6m AUD
Industry
Consumer products

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

BXN Intrinsic Value
0.06 AUD
Undervaluation 28%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.2%
=
Net Income
4.9m
/
Revenue
28.4m
What is the Net Margin of Bioxyne Ltd?

Based on Bioxyne Ltd's most recent financial statements, the company has Net Margin of 17.2%.

Back to Top